Get started
666

LUMOSA THERAPEUTICS CO LTD

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

6535 chart


Full chart

6535 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪54.69 B‬ TWD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.5 TWD
Net income (FY)
‪−238.04 M‬ TWD
Revenue (FY)
‪56.92 M‬ TWD
Shares float
‪110.33 M‬
Beta (1Y)
0.67

Employees


Employees (FY)
47
Change (1Y)
0
Revenue / Employee (1Y)
‪39.45 K‬ TWD
Net income / Employee (1Y)
‪−164.98 K‬ TWD

About LUMOSA THERAPEUTICS CO LTD


Sector
Health Technology
CEO
Jung Chin Lin
Headquarters
Taipei
Website
lumosa.com.tw
Founded
2000
ISIN
TW0006535008
FIGI
BBG009KDN2S9
Lumosa Therapeutics Co., Ltd. is a drug development company, which engages in the business of developing drugs for the central nervous system, oncology, and inflammatory diseases. It operates through the following geographical segments: Taiwan, Asia, America, and Europe. The company was founded on November 13, 2000 and is headquartered in Taipei, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

6535 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6535 is 372.5 TWD — it has increased by 4.47% in the past 24 hours. Watch LUMOSA THERAPEUTICS CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange LUMOSA THERAPEUTICS CO LTD stocks are traded under the ticker 6535.
6535 stock has risen by 13.33% compared to the previous week, the month change is a 15.79% rise, over the last year LUMOSA THERAPEUTICS CO LTD has showed a 507.05% increase.
We've gathered analysts' opinions on LUMOSA THERAPEUTICS CO LTD future price: according to them, 6535 price has a max estimate of 450.00 TWD and a min estimate of 405.00 TWD. Watch 6535 chart and read a more detailed LUMOSA THERAPEUTICS CO LTD stock forecast: see what analysts think of LUMOSA THERAPEUTICS CO LTD and suggest that you do with its stocks.
6535 reached its all-time high on Oct 28, 2024 with the price of 400.0 TWD, and its all-time low was 21.0 TWD and was reached on Mar 23, 2020. View more price dynamics on 6535 chart.
See other stocks reaching their highest and lowest prices.
6535 stock is 7.51% volatile and has beta coefficient of 0.67. Track LUMOSA THERAPEUTICS CO LTD stock price on the chart and check out the list of the most volatile stocks — is LUMOSA THERAPEUTICS CO LTD there?
Today LUMOSA THERAPEUTICS CO LTD has the market capitalization of ‪59.31 B‬, it has increased by 8.48% over the last week.
Yes, you can track LUMOSA THERAPEUTICS CO LTD financials in yearly and quarterly reports right on TradingView.
LUMOSA THERAPEUTICS CO LTD is going to release the next earnings report on Mar 3, 2025. Keep track of upcoming events with our Earnings Calendar.
6535 earnings for the last quarter are −0.55 TWD per share, whereas the estimation was −0.39 TWD resulting in a −41.03% surprise. The estimated earnings for the next quarter are −0.48 TWD per share. See more details about LUMOSA THERAPEUTICS CO LTD earnings.
LUMOSA THERAPEUTICS CO LTD revenue for the last quarter amounts to ‪7.00 M‬ TWD, despite the estimated figure of ‪10.00 M‬ TWD. In the next quarter, revenue is expected to reach ‪6.00 M‬ TWD.
6535 net income for the last quarter is ‪−227.99 M‬ TWD, while the quarter before that showed ‪67.32 M‬ TWD of net income which accounts for −438.65% change. Track more LUMOSA THERAPEUTICS CO LTD financial stats to get the full picture.
No, 6535 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 47.00 employees. See our rating of the largest employees — is LUMOSA THERAPEUTICS CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LUMOSA THERAPEUTICS CO LTD EBITDA is ‪−336.88 M‬ TWD, and current EBITDA margin is −619.19%. See more stats in LUMOSA THERAPEUTICS CO LTD financial statements.
Like other stocks, 6535 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LUMOSA THERAPEUTICS CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LUMOSA THERAPEUTICS CO LTD technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LUMOSA THERAPEUTICS CO LTD stock shows the buy signal. See more of LUMOSA THERAPEUTICS CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.